Biotech

All Articles

Kairos goes public along with $6M IPO to money tests of cancer drug

.Along with a trio of biotechs hitting the Nasdaq on Friday, it was quick and easy to miss a smaller...

Vaccine and Keytruda combo helpful in squamous cell cancer

.Immune gate preventions are the superheroes of cancer treatment. Medications like Bristol Myers Squ...

Cue Biopharma mark time J&ampJ veterinarian as CBO-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of substantial leadership hirings, shootings ...

Regeneron's Opdualag rival reveals 57% feedback price

.Regeneron is back along with long-term consequence for its own LAG-3 prevention and also PD-1 inhib...

AstraZeneca blog posts information on internal competitors to AbbVie, Pfizer ADCs

.AstraZeneca has shared an early check out the efficiency of its internal antibody-drug conjugate (A...

iTeos- GSK's TIGIT celebrity presents relevant improvement

.After introducing a stage 3 launch based upon positive midstage end results, iTeos and GSK are even...

More joint FDA can speed up uncommon condition R&ampD: record

.The FDA needs to be more available and also joint to discharge a surge in approvals of uncommon ill...

Zenas, MBX, Bicara scalp to Nasdaq in very hot time for biotech IPOs

.It's an abnormally hectic Friday for biotech IPOs, with Zenas BioPharma, MBX and also Bicara Therap...

Atea's COVID antiviral neglects to halt hospitalizations in period 3

.Atea Pharmaceuticals' antiviral has stopped working an additional COVID-19 test, however the biotec...

Neurocrine's proposal to conserve mental illness prospect falls short

.Neurocrine Biosciences' mental illness course pivot has actually failed. The biotech was actually u...